The introduction of electronic prescriptions in Ukraine as an important component of the electronic healthcare system: the experience of pharmacists
DOI:
https://doi.org/10.24959/sphhcj.25.358Keywords:
antibiotics; electronic prescription; electronic health system; pharmacistAbstract
The electronic prescription plays an important role in the digitalization of the healthcare system in Ukraine and is an important tool for managing the supply of medicines. The introduction of e-prescriptions brings the national healthcare system of Ukraine in line with international standards, in particular in the context of European integration obligations. The e-prescription provides transparency, accounting and control of the turnover of prescription drugs, contributes to the rationalization of pharmacotherapy and increases the responsibility of all participants in this process.
Aim. To analyze the impact of e-prescriptions on the work of pharmacists, assess the advantages and problems they face during their introduction, as well as determine future development directions for the e-prescription system to improve the efficiency of pharmaceutical services.
Materials and methods. The methods used included questionnaire surveys, analysis and synthesis, formal-logical, semantic, comparative, and systemic methods. The data analysis was performed using Microsoft Office Excel and STATISTICA 12.
Results and discussion. Our study found that the level of satisfaction among pharmacists with the e-prescription system implemented in Ukraine was quite high, with an average score of 7.79±2.02. According to the survey results, the average value of the number of e-prescriptions dispensed by one pharmacist during the working day was 6.95±0.41 prescriptions. At the same time, the average number of e-prescriptions for antibiotics was significantly lower – 1.60±0.19 prescriptions per day. Additionally, the average time to dispense one e-prescription, as reported by the respondents, was 2.63 minutes. The positive aspects of electronic prescribing that were most frequently mentioned in the free-text responses were safety of avoiding defects inherent in paper prescriptions (262) and the reduction in the likelihood of uncontrolled antibiotic consumption (295). However, respondents also described several disadvantages of electronic prescribing of medicines.
Conclusions. The results of the study have shown that the introduction of the electronic prescription in the pharmacy practice of Ukraine is an important step towards the digitalization of pharmacy and strengthening control over the turnover of prescription drugs, particularly antibiotics. Most pharmacists support the idea of the e-prescription as a tool for rationalizing the drug dispensing process, reducing abuse, and increasing the transparency of pharmaceutical care.
References
Kõnd, K., & Lilleväli, A. (2019). E-prescription success in Estonia: The journey from paper to pharmacogenomics. Eurohealth, 25(2), 18–20. https://apps.who.int/iris/bitstream/handle/10665/332593/Eurohealth-25-2-18-20-eng.pdf
Peltoniemi, T., Suomi, R., Peura, S., & Lähteenoja, M. N. Y. (2021). Electronic prescription as a driver for digitalization in Finnish pharmacies. BMC Health Services Research, 21, 1017. https://doi.org/10.1186/s12913-021-07003-0
Kowalczyk, M., Hermanowski, T., & Kolasa, K. (2023). Badanie opinii polskich farmaceutów na temat perspektywy wdrożenia systemu e-recepty i elektronicznej dokumentacji medycznej. Roczniki Kolegium Analiz Ekonomicznych, 42(23), 327–338. https://rocznikikae.sgh.waw.pl/p/roczniki_kae_z42_23.pdf
Digital prescription. G_NIUS - Guichet National de l’Innovation et des Usages en e-Santé. G_NIUS. (n.d.). https://gnius.esante.gouv.fr/en/regulations/regulation-profiles/digital-prescription
Graf, A., Fehring, L., Henningsen, M., & Zinner, M. (2023). Going digital in Germany: An exploration of physicians’ attitudes towards the introduction of electronic prescriptions - A mixed methods approach. International Journal of Medical Informatics, 174, 105063. https://doi.org/10.1016/j.ijmedinf.2023.105063
Vidpusk retsepturnykh likiv za e-retseptom - roziasnennia dlia farmatsevtiv. (2023). Ministerstvo okhorony zdorovia Ukrainy. https://moz.gov.ua/uk/vidpusk-recepturnih-likiv-za-e-receptom-%E2%80%93-roz%CA%BCjasnennja-dlja-farmacevtiv
Rea, L. M., & Parker, R. A. (1992). Designing and conducting survey research. Jossey-Bass.
Bilgener, E., & Bulut, S. (2021). Evaluation of electronic prescriptions in Turkey: A community pharmacy perspective. Health Policy and Technology, 10(1), 52–59. https://doi.org/10.1016/j.hlpt.2020.11.003
Grossman, J. M., Cross, D. A., Boukus, E. R., & Cohen, G. R. (2012). Transmitting and processing electronic prescriptions: Experiences of physician practices and pharmacies. Journal of the American Medical Informatics Association, 19(3), 353–359. https://doi.org/10.1136/amiajnl-2011-000515
Hammar, T., Nyström, S., Petersson, G., Rydberg, T., & Åstrand, B. (2010). Swedish pharmacists value ePrescribing: A survey of a nationwide implementation. Journal of Pharmaceutical Health Services Research, 1(1), 23–32. https://doi.org/10.1211/jphsr.01.01.0012
Tereschenko, L. V., Korzh, I. V., Tereschenko, O. S., Volkova, A. V., & Afanasenko, O. V. (2024). The assessment of the state of prescription dispensing by pharmacists in the context of the electronic prescription introduction in Ukraine. Social Pharmacy in Health Care, 10(2), 54–62. https://doi.org/10.24959/sphhcj.24.319
Koval, V. M., Kryvoviaz, O. V., & Mykhalevych, V. M. (2024). Analiz trudnoshchiv vidpusku likarskykh zasobiv za elektronnymy retseptamy. Farmatsevtychnyi chasopys, (4), 64–72. https://doi.org/10.11603/2312-0967.2024.4.14933
Grammatikopoulou, M., Lazarou, I., Giannios, G., Kakalou, C. A., Zachariadou, M., Zande, M., Karanikas, H., Thireos, E., Stavropoulos, T. G., Natsiavas, P., Nikolopoulos, S., & Kompatsiaris, I. (2024). Electronic prescription systems in Greece: A large-scale survey of healthcare professionals’ perceptions. Archives of Public Health, 82, 68. https://doi.org/10.1186/s13690-024-01304-6
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 National University of Pharmacy
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
